BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20364881)

  • 1. Mineralocorticoid receptor antagonism prevents hedonic deficits induced by a chronic sodium appetite.
    Morris MJ; Na ES; Johnson AK
    Behav Neurosci; 2010 Apr; 124(2):211-24. PubMed ID: 20364881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of deoxycorticosterone-induced sodium appetite on hedonic behaviors in the rat.
    Morris MJ; Na ES; Grippo AJ; Johnson AK
    Behav Neurosci; 2006 Jun; 120(3):571-9. PubMed ID: 16768609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
    Sakai RR; McEwen BS; Fluharty SJ; Ma LY
    Kidney Int; 2000 Apr; 57(4):1337-45. PubMed ID: 10760064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.
    Eudy RJ; Sahasrabudhe V; Sweeney K; Tugnait M; King-Ahmad A; Near K; Loria P; Banker ME; Piotrowski DW; Boustany-Kari CM
    J Transl Med; 2011 Oct; 9():180. PubMed ID: 22017794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine changes associated with a rapidly developing sodium appetite in rats.
    Thunhorst RL; Morris M; Johnson AK
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1168-73. PubMed ID: 7977842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apparent dependence of salt appetite in the pigeon on endogenous angiotensin II.
    Massi M; Epstein AN
    Physiol Behav; 1987; 41(2):155-62. PubMed ID: 2960995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin, arterial blood pressure, and salt appetite in rats.
    Thunhorst RL; Johnson AK
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R458-65. PubMed ID: 8141403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
    Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
    Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
    Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
    Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt appetite is suppressed by interference with angiotensin II and aldosterone.
    Sakai RR; Nicolaïdis S; Epstein AN
    Am J Physiol; 1986 Oct; 251(4 Pt 2):R762-8. PubMed ID: 3532826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    J Hypertens; 2002 Sep; 20(9):1829-34. PubMed ID: 12195126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
    Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
    Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced hedonic behavior and altered cardiovascular function induced by mild sodium depletion in rats.
    Grippo AJ; Moffitt JA; Beltz TG; Johnson AK
    Behav Neurosci; 2006 Oct; 120(5):1133-43. PubMed ID: 17014263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
    Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
    Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rats exhibit aldosterone-dependent sodium appetite during 24 h hindlimb unloading.
    Sullivan MJ; Hasser EM; Moffitt JA; Bruno SB; Cunningham JT
    J Physiol; 2004 Jun; 557(Pt 2):661-70. PubMed ID: 15047775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect on salt appetite and the renin-aldosterone system on replacing the depleted ions to sodium-deficient cattle.
    Bell FR; Drury PL; Sly J
    J Physiol; 1981; 313():263-74. PubMed ID: 7024508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independence of salt intake induced by calcium deprivation from the renin-angiotensin-aldosterone system.
    Tordoff MG; Pilchak DM; Hughes RL
    Am J Physiol; 1993 Mar; 264(3 Pt 2):R492-9. PubMed ID: 8457002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of renin-angiotensin-aldosterone system in NaCl appetite of rats.
    Fregly MJ; Rowland NE
    Am J Physiol; 1985 Jan; 248(1 Pt 2):R1-11. PubMed ID: 3881982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSR-71167, a novel mineralocorticoid receptor antagonist with carbonic anhydrase inhibitory activity, separates urinary sodium excretion and serum potassium elevation in rats.
    Nariai T; Fujita K; Kawane K; Mori M; Nakayama R; Matsuda K; Katayama S; Fukuda N; Hori S; Iwata M; Hasegawa F; Suzuki K; Kato H
    J Pharmacol Exp Ther; 2015 Jul; 354(1):2-9. PubMed ID: 25922341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.